News Nation on MSN

Eli Lilly, Novo Nordisk near deal on weight loss drug costs: Report

According to Reuters, Lilly could offer the lowest dose of its popular weight loss drug Zepbound at $149 a month, and Novo’s ...

Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly

COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year forecasts on Wednesday as sales growth of its ...

Novo Nordisk latest outlook trim shows “quick momentum loss”

Novo Nordisk has cut its outlook for 2025 as lower expectations for glucagon-like peptide-1 receptor agonists (GLP-1RA) continue to hit the drugmaker. Net profit for Q3 came in at Dkr20bn ($3.1bn), ...
Investing.com UK

Trump expected to announce deal with Eli Lilly, Novo Nordisk on weight loss drugs

Investing.com -- U.S. President Donald Trump is expected to announce a deal with officials from Eli Lilly and Novo Nordisk that would cut the price of weight loss drugs to $150 a month in some cases, ...

Novo Nordisk strikes pricing deal that will impact cost of Ozempic and Wegovy for millions

Ozempic maker Novo Nordisk has agreed to a deal that will lower the price of blockbuster weight-loss drugs for millions.

Trump administration nearing deal to cut prices on popular weight-loss drugs, reports say

The Trump administration is reportedly finalizing a deal with Eli Lilly and Novo Nordisk that would lower prices on Wegovy, ...